WordNet

stake on the outcome of an issue; "I bet $100 on that new horse"; "She played all her money on the dark horse" (同)wager, play
the act of gambling; "he did it on a bet" (同)wager
maintain with or as if with a bet; "I bet she will be there!" (同)wager
second in order of importance; "the candidate, considered a beta male, was perceived to be unable to lead his party to victory"
the 2nd letter of the Greek alphabet
preliminary or testing stage of a software or hardware product; "a beta version"; "beta software"

PrepTutorEJDIC

『かけ』・(…との)かけ《+『with』+『名』》 / かけた物(金) / かけの対象 / 〈金・物〉'を'『かける』 / (かけ事・ゲームなどで)〈人〉‘と'『かけをする』《+『名』〈人〉+『on』+『名』》 / (…に)『かける』《+『on』(『against』)+『名』(one's do『ing』)》
ベータ(ギリシア語アルファベットの第2文字;B,β;英語のB,b に遭当)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Human adenovirus type 37 uses αVβ1 and α3β1 integrins for infection of human corneal cells.

Storm RJ1, Persson BD1, Nygård Skalman L2, Frängsmyr L1, Lindström M3, Rankin G4, Lundmark R2,3, Pedrosa Domellöf F5,3, Arnberg N6.
Journal of virology.J Virol.2016 Dec 14. pii: JVI.02019-16. [Epub ahead of print]
Epidemic keratoconjunctivitis (EKC) is a severe, contagious ocular disease that affects 20-40 million individuals worldwide every year. EKC is mainly caused by six types of human adenovirus (HAdV): HAdV-8, -19, -37, -53, -54, and -56. Of these, HAdV-8, -19, and -37 use sialic acid-containing glycans
PMID 27974569

Colburn ZT1, Jones JC2.
American journal of respiratory cell and molecular biology.Am J Respir Cell Mol Biol.2016 Dec 6. [Epub ahead of print]
α6β4 integrin is localized in a unique punctate distribution at the cell-substratum interface along the leading front of single, front-rear polarized, A549 cells. These puncta are interspersed between focal adhesions and lack association with the actin cytoskeleton. Knockdown of β4 integrin in A5
PMID 27922761

Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro.

Juengel E1,2, Maxeiner S1, Rutz J1, Justin S1, Roos F1, Khoder W1, Tsaur I1, Nelson K3, Bechstein WO1,4, Haferkamp A1, Blaheta RA1.
Oncotarget.Oncotarget.2016 Nov 17. doi: 10.18632/oncotarget.13421. [Epub ahead of print]
Although the mechanistic target of rapamycin (mTOR) inhibitor, everolimus, has improved the outcome of patients with renal cell carcinoma (RCC), improvement is temporary due to the development of drug resistance. Since many patients encountering resistance turn to alternative/complementary treatment
PMID 27863441